Blog

 

■ Predictors of good long-term renal outcomes in lupus nephritis: results from a single lupus cohort

W A Fung, J Su, Z Touma

BioMed Research International 2017 (2017), Article ID 5312960, 8 pages

https://www.hindawi.com/journals/bmri/2017/5312960/

 

■ Predictors of incident proteinuria among patients with SLE

A Duarte-García, E Barr, L S Magder, M Petri

Lupus Science & Medicine 2017, vol 4 (1)

http://lupus.bmj.com/content/4/1/e000200

 

■ Early proteinuria response: a valid real-life situation predictor of long-term lupus renal outcome in an ethnically diverse group with severe biopsy-proven nephritis?

M R Ugolini-Lopes, L P C Seguro, M X F Castro et al

Lupus Science & Medicine 2017, vol 4 (1)

http://lupus.bmj.com/content/4/1/e000213

 

■ Safety, pharmacokinetics and pharmacodynamics of AMG 811, an anti-interferon-Ymonoclonal antibody, in SLE subjects without or with lupus nephritis

M J Boedigheimer, D A Martin, Z Amoura et al

Lupus Science & Medicine 2017, vol 4 (1)

http://lupus.bmj.com/content/4/1/e000226

 

■ The value of repeat biopsy in lupus nephritis flares

J Narváez, M Ricse, M Gomà et AL

Medicine 2017, vol 96 (24)

http://journals.lww.com/md-journal/Fulltext/2017/06160/The_value_of_repeat_biopsy_in_lupus_nephritis.14.aspx

 

■ Control of lupus nephritis by changes of gut microbiota

Q Mu, H Zhang, X Liao et al

Microbiome 217, vol 175: 73

https://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-017-0300-8

 

■ Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis

S Yung, D Y H Yap, T M Chan

Version 1. F1000Res jun 2017

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473406/

 

■ Frequency of dyspipidemia in patients with lupus nephritis

S Sajjad, S Farman, M A Saeed et al

Pak J Med Sci 2017, vol 33 (2): 358-362

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432704/

 

■ Recomendaciones y sugerencias a 4 preguntas clave en nefropatía lúpica: Extracto de la guía de práctica clínica 2015

Martín-Gómez, María Adoración et al.

Nefrología (Madr.), Ago 2016, vol.36, no.4, p.333-338

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952016000400333&lng=es&nrm=iso

 

■ The history of pulse therapy in lupus nephritis

M Scheinberg

Lupus Science & Medicine 2016, vol 3 (1)

http://lupus.bmj.com/content/3/1/e000149

 

■ Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythmatosus (SLE) and non-SLE recipients

R Ramsey-Goldman, A Brar et al

Lupus Science & Medicine 2016, vol 3 (1)

http://lupus.bmj.com/content/3/1/e000156

 

■ Interferon (IFN)- λ is a potential mediator in lupus nephritis

A Zickert, V Oke, I Parodis et al

Lupus Science & Medicine 2016, vol 3 (1)

http://lupus.bmj.com/content/3/1/e000170

 

■ Renal iron accumulation occurs in lupus nephritis and iron chelation delays the onset of albuminuria

E S Marks, M L Bonnemaison, S K Brusnahan et al

Scientific Reports 2017, Article number: 12821

http://www.nature.com/articles/s41598-017-13029-4

 

■ Update on lupus nephritis

S Almaani, A Meara, B H Rovin

CJASN 2017, vol 12 (5): 825-835

http://cjasn.asnjournals.org/content/12/5/825.full

 

■ Tacrolimus-based regimens in lupus nephritis

T Kraaij, O W Bredewold, S Trompet et al

Lupus Science & Medicine 2016, vol 3

http://lupus.bmj.com/content/lupusscimed/3/1/e000169.full.pdf

 

■ Treatment for lúpus nephritis: a systemic review and network metaanalysis

J A Singh, A Hossain, A Kotb et al

Journal of Rheumatology 2016, vol 43 (10): 1801-1812

http://www.jrheum.org/content/43/10/1801

 

■ Nefropatia por IgA em paciente portadora de lúpus eritematoso sistêmico: relato de caso e revisão de literatura

Silva, Leonardo Sales da et AL

Rev. Bras. Reumatol., June 2016, vol.56, no.3, p.270-273

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042016000300270&lng=en&nrm=iso&tlng=pt

 

■ As deficiências leve e moderada de lectina ligadora de manose estão associadas ao lúpus eritematoso sistêmico e à nefrite lúpica em pacientes brasileiros.

Perazzio, Sandro Félix et AL

Rev. Bras. Reumatol., June 2016, vol.56, no.3, p.220-227

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042016000300220&lng=en&nrm=iso&tlng=pt

 

■ Consenso da Sociedade Brasileira de Reumatologia para o diagnóstico, manejo e tratamento da nefrite lúpica.

Klumb, Evandro Mendes et al.

Rev. Bras. Reumatol., Fev 2015, vol.55, no.1, p.1-2

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042015000100001&lng=en&nrm=iso

 

■ Recomendaciones sobre el manejo del compromiso renal del lupus eritematoso sistémico: Documento de Consenso de las Sociedades Chilenas de Nefrología y Reumatología

Aguirre, Verónica et al

Rev. méd. Chile, Dic 2015, vol.143, no.12, p.1569-1578

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872015001200010&lng=en&nrm=iso

 

■ Lupus nephritis management guidelines compared

S Wilhelmus, I M Bajema, G K Bertsias et al

Nephrology Dialysis Transplantation 2016, vol 31 (6): 904-913

https://academic.oup.com/ndt/article/31/6/904/1751757/Lupus-nephritis-management-guidelines-compared

 

■ The pathogenesis, diagnosis and treatment of lupus nephritis

N Schwartz, B Goilav, C Putterman

Curr Opin Rheumatol 2014, vol 26 (5): 502-509

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221732/

 

■ Detecção de podocitúria em pacientes com nefrite lúpica

Sabino, Amelia Rodrigues Pereira et al.

1. Bras. Nefrol., Dez 2013, vol.35, no.4, p.252-258

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002013000400004&lng=en&nrm=iso

 

■ CKD-EPI is the most reliable equation to estimate renal function in patients with systemic lupus erythematosus.

Martínez-Martínez, Marco U. et al.

Nefrología (Madr.), 2013, vol.33, no.1, p.99-106

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952013000100011&lng=es&nrm=iso&tlng=en

 

■ Relação proteína/creatinina na urina versus proteinúria de 24 horas na avaliação de nefrite lúpica.

Solorzano, Grace Tamara Moscoso et AL

1. Bras. Nefrol., Mar 2012, vol.34, no.1, p.64-67

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002012000100010&lng=en&nrm=iso

 

■ Tratamiento inmunosupresor de nefritis lúpica en insuficiencia renal grave.: Sobre el estudio ALMS

Martín-Gómez, Adoración.

Nefrología (Madr.), 2012, vol.32, no.5, p.679-680

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0211-69952012000700020&lng=es&nrm=iso

 

■ Are serum cystatin C levels influenced by steroid doses in lupus nephritis patients?.

Madureira e Silva, Marcus Vinicius et al.

1. Bras. Nefrol., Sept 2011, vol.33, no.3, p.306-312

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002011000300006&lng=en&nrm=iso&tlng=en

 

■ Avaliação de 100 pacientes com nefrite lúpica acompanhados por dois anos.

Melo, Ana Karla Guedes de et al.

Rev. Bras. Reumatol., Fev 2009, vol.49, no.1, p.8-19

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0482-50042009000100002&lng=en&nrm=iso

 

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

31 30033306       /   40204020

CRMMG: 7026

Email: pfleite1873@gmail.com

 

■ Advances in the understading of priapism

Matthew Hudnall, Amanda B. Reed-Maldonado, Tom F. Lue

Transl Androl Urol. 2017 Apr; 6(2): 199–206

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422696/

 

■ Daily use of phosphodiesterase type 5 inhibitors as prevention for recurrent priapism

Nardozza Junior, Archimedes and Cabrini, Marcelo Rodrigues

Rev. Assoc. Med. Bras., Aug 2017, vol.63, no.8, p.689-692

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302017000800689&lng=en&nrm=iso&tlng=en

 

■ Contemporary best practice in the evaluation and management of stuttering priapism

Kousournas G, Muneer A, Ralph D, Zacharakis E.

Ther Adv Urol. 2017, vol 9(9-10):227-238

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598804/

 

■ The semantics of priapism and the first sign of chronic myeloid leukemia

Michael R. Minckler, Ellie Conser, Javier J. Figueroa et al

Case Rep Emerg Med. 2017; 2017: 2656203

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468559/

 

■ Ischemic priapism: Can eosinophil count and platelet functions be positive predictive factors in etiopathogenesis

Mehmet Giray Sönmez, Cengiz Kara, Adnan Karaibrahimoğlu, et al

Can Urol Assoc J. 2017 vol 11(7): E297–E301

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519389/

 

■ Avoiding complications: surgery for ischemic priapism

A B Reed-Maldonado, J S Kim, T F Lue

Transl Androl Urol 2017, vol 6 (4): 657-665

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583045/

 

■ Surgical treatment of priapsim in sickle cell patients: a noble therapy in preserving erection

A Bello, H Y Maitama, M Ahmed, A Sudi

Arch Int Surg 2016, vol 6:12-16

http://www.archintsurg.org/article.asp?issn=2278-9596;year=2016;volume=6;issue=1;spage=12;epage=16;aulast=Bello

 

■ Clinical management of priapism: a review

Kazuyoshi Shigehara, Mikio Namiki

World J Mens Health. 2016 Apr; 34(1): 1–8.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853765/

 

■ Management of priapism in adult men

Onyeanunam N. Ekeke, Hannah E. Omunakwe, Ndu Eke

Int Surg. 2015 Mar; 100(3): 552–557

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370551/

 

■ Emergency department visits and inpatient admissions associated with priapism among males with sickle cell disease in the United States, 2006-2010

Brandi Dupervil, Scott Grosse, Arthur Burnett, Christopher Parker

PLoS One. 2016; 11(4): e0153257

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831774/

 

■ Management of refractory ischemic priapism: current perspectives

Marco Capece, Arianna Gillo, Andrea Cocci, Giulio Garaffa, Massimiliano Timpano, Marco Falcone

Res Rep Urol. 2017;  vol 9: 175–179

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587151/

 

■ Management in neonatal priapism: case and review

Andre Yoichi Kuwano, Alexandre Cavalcante, André Costa-Matos, Ezequiel Fabiane Spanholi, Frederico Mota Mascarenhas de Souza

Urol Case Rep. 2017, vol 14: 48–49

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522373/

 

■ Acute scrotal pain and priapism: An early signof progression in metastatic renal cell carcinoma?

Kunal Patel, Benjamin W Lamb, Kathryn Hawkesford, John L Peters

BMJ Case Rep. 2015; 2015: bcr2014208228

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336893/

 

■ How I treat priapism

Uzoma A. Anele, Brian V. Le, Linda M. S. Resar, Arthur L. Burnett

Blood. 2015 Jun 4; 125(23): 3551–3558.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458797/

 

■ Molecular pathophysiology of priapism: emerging targets

Uzoma A. Anele, Belinda F. Morrison, Arthur L. Burnett

Curr Drug Targets. 2015; 16(5): 474–483

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430197/

 

■ Management of priapism: na updte for clinicians

Helen R. Levey, Robert L. Segal, Trinity J. Bivalacqua

Ther Adv Urol. 2014 Dec; 6(6): 230–244

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236300/

 

■ European Association of Urology Guidelines on Priapism

A Salonia, I Eardley, F Giuliano et al

European Urology 2014, vol 65 (2): 480-489

http://www.europeanurology.com/article/S0302-2838(13)01205-0/fulltext

 

■ Priapism in sickle cell disease: a hematologist´s perspective

Gregory J. Kato

J Sex Med. 2012 Jan; 9(1): 70–78

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253142/

 

■ Priapism: pathophysiology and the role of the radiologist

J E Halls, D V Patel, M Walkden, U Patel

Br J Radiol. 2012 Nov; 85(Spec Iss 1): S79–S85

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746404/

 

■ Priapismo secundario a antipsicóticos: a propósito de un caso asociado a risperidona

Cruzado, Lizardo and Vallejos, César E

Rev. méd. Chile, Nov 2012, vol.140, no.11, p.1445-1448

http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872012001100010&lng=en&nrm=iso

 

■ Priapismo recurrente (“stuttering priapism”): presentación de un nuevo caso y revisión de la literatura

Molina Escudero, Roberto et al.

Arch. Esp. Urol., Set 2010, vol.63, no.7, p.554-558

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0004-06142010000700014&lng=en&nrm=iso

 

■ Priapismo secundario a tratamiento por cabergolina: primera descripción de esta asociación

La Peña Zarzuelo, E. De, Hernández Cañas, V. and Llorente Abarca, C.

Actas Urol Esp, Mayo 2010, vol.34, no.5, p.487-488

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062010000500018&lng=en&nrm=iso

 

■ Priapismo em crianças: revisão de fisiopatologia e tratamento.

Jesus, Lisieux Eyer de and Dekermacher, Samuel

1. Pediatr. (Rio J.), Jun 2009, vol.85, no.3, p.194-200

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572009000300003&lng=pt&nrm=iso

 

■ Priapismo maligno secundario a cancer de vejiga

Eguíluz Lumbreras, Pablo et al.

Arch. Esp. Urol., Abr 2009, vol.62, no.3, p.239-241

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0004-06142009000300013&lng=en&nrm=iso

 

■ . Priapismo secundario a infiltración peneana por contigüidad de carcinoma vesical infiltrante

Celma Domènech, Ana et a

Actas Urol Esp, Mar 2009, vol.33, no.3, p.327-329

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0210-48062009000300019&lng=en&nrm=iso

 

■ by Dr Paulo Fernando Leite

Cardiologia – Centro Médico Unimed BH

Rua Gonçalves Dias 202

Belo Horizonte/MG/Brasil

31 30033306       /   40204020

CRMMG: 7026

Email: pfleite1873@gmail.com